Stocks › APVO
Aptevo Therapeutics Inc.
APVO·Nasdaq·
United States·USD
United States·USD$1.79
-0.01 (-0.28%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
APVO
Aptevo Therapeutics Inc. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
APVOS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of APVO by members of U.S. Congress · 1 on record
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
 Steve CohenHouse · D · TN |
APVOAptevo Therapeutics Inc. · Stock |
Sale $470.99 |
Jul 3, 2019 | Jun 24, 2019 | Filing ↗ |
Whale Activity
Position changes in APVO reported for 2026-06-30 by 1 tracked institutional filer
- Increased0
- New0
- Held1
- Decreased0
- Closed0
- No prior filing0
| Filer | Shares | Value | Change |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 12.7K | $56K | held |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by APVO insiders, by quarter · Form 4
Recent Insider Transactions
193 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Grant Grady IIIDirector | Purchase | +13.5K | $1.49 | $20K | Nov 10, 2025 | Form 4 ↗ |
| Harsanyi ZsoltDirector | Option exercise | +1 | — | — | Jul 17, 2025 | Form 4 ↗ |
| Kunz Barbara LopezDirector | Option exercise | +1 | — | — | Jul 17, 2025 | Form 4 ↗ |
| Abdun-Nabi DanielDirector | Option exercise | +1 | — | — | Jul 17, 2025 | Form 4 ↗ |
| Grant Grady IIIDirector | Option exercise | +1 | — | — | Jul 17, 2025 | Form 4 ↗ |
| Niederhuber JohnDirector | Option exercise | +1 | — | — | Jul 17, 2025 | Form 4 ↗ |
| Taylor DaphneSVP, CFO | Option exercise | +3 | — | — | Jul 17, 2025 | Form 4 ↗ |
| Kwon SoYoungSVP, GC, BD & Corp Affairs | Option exercise | +3 | — | — | Jul 17, 2025 | Form 4 ↗ |
| White Marvin LPresident and CEO · Director | Option exercise | +10 | — | — | Jul 17, 2025 | Form 4 ↗ |
| Lamothe Jeffrey G.EVP, COO | Option exercise | +5 | — | — | Jul 17, 2025 | Form 4 ↗ |
| Taylor DaphneSVP, CFO | Option exercise | +1 | — | — | Mar 4, 2025 | Form 4 ↗ |
| Kwon SoYoungSVP, GC, BD & Corp Affairs | Option exercise | +2 | — | — | Mar 3, 2025 | Form 4 ↗ |
| Lamothe Jeffrey G.EVP, COO | Option exercise | +2 | — | — | Mar 3, 2025 | Form 4 ↗ |
| White Marvin LPresident and CEO · Director | Option exercise | +6 | — | — | Mar 3, 2025 | Form 4 ↗ |
| Kwon SoYoungSVP, GC, BD & Corp Affairs | Option exercise | +2 | — | — | Mar 2, 2025 | Form 4 ↗ |
| Lamothe Jeffrey G.EVP, COO | Option exercise | +3 | — | — | Mar 2, 2025 | Form 4 ↗ |
| White Marvin LPresident and CEO · Director | Option exercise | +8 | — | — | Mar 2, 2025 | Form 4 ↗ |
| Taylor DaphneSVP, CFO | Option exercise | +2 | — | — | Mar 2, 2025 | Form 4 ↗ |
| Kwon SoYoungSVP, GC, BD & Corp Affairs | Option exercise | +213 | — | — | Aug 8, 2024 | Form 4 ↗ |
| Lamothe Jeffrey G.EVP, COO | Option exercise | +272 | — | — | Aug 8, 2024 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding APVO · SEC Form N-PORT
No mutual fund or ETF has reported APVO in an N-PORT filing in the last seven months.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- Heights Capital Management, Inc.SCHEDULE 13G/A · passive (13G) · 83.9K shares6.3%
Aug 14, 2026 · ↗ - CVI Investments, Inc.SCHEDULE 13G/A · passive (13G) · 83.9K shares6.3%
Aug 14, 2026 · ↗ - NIOWAVE, INC.SCHEDULE 13G · passive (13G) · 151.7K shares12.2%
Jun 22, 2026 · ↗ - BANK OF AMERICA CORP /DE/SCHEDULE 13G/A · passive (13G) · 86 shares0.0%
Nov 7, 2025 · ↗ - BANK OF AMERICA CORP /DE/SCHEDULE 13G · passive (13G) · 494.3K shares15.0%
Oct 6, 2025 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming Aptevo Therapeutics Inc. as client
No lobbying filings found naming Aptevo Therapeutics Inc. as the client.
Government Contracts
Federal awards to Aptevo Therapeutics Inc. · USAspending
No federal contract awards found for Aptevo Therapeutics Inc..
U.S. Patents
Recent USPTO applications naming Aptevo Therapeutics Inc.
No USPTO patent applications found for Aptevo Therapeutics Inc..
Annual Financials
From APVO's 10-K filings · XBRL
No annual XBRL figures on record for APVO. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
- 1-for-18Reverse splitDec 30, 2025
- 1-for-20Reverse splitMay 27, 2025
- 1-for-37Reverse splitDec 4, 2024
- 1-for-44Reverse splitMar 6, 2024
- 1-for-14Reverse splitMar 27, 2020
Split dates and ratios from the price history · Close Prices from Tiingo.com
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 8.01, 9.01Other eventsSep 24, 2026
EDGAR ↗ - 8-K · Items 5.07Shareholder voteSep 23, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsSep 3, 2026
EDGAR ↗ - 8-K · Items 5.07Shareholder voteAug 21, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsAug 14, 2026
EDGAR ↗ - 8-K · Items 1.01, 3.02, 8.01, 9.01Material agreement · Unregistered sale of equity · Other eventsAug 13, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsJul 27, 2026
EDGAR ↗ - 8-K · Items 1.01, 7.01, 9.01Material agreement · Reg FD disclosureJun 30, 2026
EDGAR ↗ - 8-K · Items 1.01, 3.02, 7.01, 9.01Material agreement · Unregistered sale of equity · Reg FD disclosureMay 27, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsMay 13, 2026
EDGAR ↗
About Aptevo Therapeutics Inc.
From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersSEATTLE, WA
IncorporatedDE
SEC CIK0001671584 ↗